Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001509037 | SCV001715535 | uncertain significance | not provided | 2019-04-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003145681 | SCV003830553 | uncertain significance | Developmental and epileptic encephalopathy, 23 | 2022-05-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003145681 | SCV004178458 | uncertain significance | Developmental and epileptic encephalopathy, 23 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
3billion | RCV003145681 | SCV005328624 | likely benign | Developmental and epileptic encephalopathy, 23 | 2024-09-20 | criteria provided, single submitter | clinical testing | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. |